CEO: | Jeremy Skillington |
CFO: | Ian O’Connel |
Executive Chairman: | Cathal Friel |
Independent Non-Executive Director: | Edward Gibson |
Independent Non-Executive Director: | Luke O’Neill |
Independent Non-Executive Director: | Brendan Buckley |
Non-Executive Dir: |
Address: | 40 Bank Street, Floor 24, London, United Kingdom, E14 5NR |
Phone: | +44 (0)20 7183 1499 |
Website: | http://www.poolbegpharma.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BKPG7Z60 |
Currency | UK Pounds |
Share Price | 3.23p |
Change Today | -0.52p |
% Change | -13.78 % |
52 Week High | 14.25 |
52 Week Low | 2.40 |
Volume | 4,308,689 |
Shares Issued | 500.00m |
Market Cap | £16.17m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:03 | 31,031 @ 3.22p |
15:02 | 8,878 @ 3.12p |
14:27 | 500,000 @ 3.20p |
14:27 | 2,933 @ 3.15p |
14:24 | 9,180 @ 3.15p |
CEO | Jeremy Skillington |
CFO | Ian O’Connel |
You are here: research